This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Sep;5(9):1315-9.

doi: 10.2217/fmb.10.99.

Azithromycin paradox in the treatment of cystic fibrosis airway disease

Christopher D Sibley¹, Margot E Grinwis, Harvey R Rabin, Michael G Surette

Affiliations

PMID: 20860478
DOI: 10.2217/fmb.10.99

Comment

Azithromycin paradox in the treatment of cystic fibrosis airway disease

Christopher D Sibley et al. Future Microbiol. 2010 Sep.

. 2010 Sep;5(9):1315-9.

doi: 10.2217/fmb.10.99.

Authors

Christopher D Sibley¹, Margot E Grinwis, Harvey R Rabin, Michael G Surette

Affiliation

¹ Department of Microbiology & Infectious Diseases, University of Calgary, Alberta, Canada.

PMID: 20860478
DOI: 10.2217/fmb.10.99

No abstract available

PubMed Disclaimer

Comment on

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
Saiman L, Anstead M, Mayer-Hamblett N, Lands LC, Kloster M, Hocevar-Trnka J, Goss CH, Rose LM, Burns JL, Marshall BC, Ratjen F; AZ0004 Azithromycin Study Group. Saiman L, et al. JAMA. 2010 May 5;303(17):1707-15. doi: 10.1001/jama.2010.563. JAMA. 2010. PMID: 20442386 Clinical Trial.

Similar articles

Azithromycin increases chloride efflux from cystic fibrosis airway epithelial cells.
Oliynyk I, Varelogianni G, Schalling M, Asplund MS, Roomans GM, Johannesson M. Oliynyk I, et al. Exp Lung Res. 2009 Apr;35(3):210-21. doi: 10.1080/01902140802534967. Exp Lung Res. 2009. PMID: 19337904 Clinical Trial.
Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice.
Gavilanes X, Huaux F, Meyer M, Lebecque P, Marbaix E, Lison D, Scholte B, Wallemacq P, Leal T. Gavilanes X, et al. J Cyst Fibros. 2009 May;8(3):203-10. doi: 10.1016/j.jcf.2009.03.003. Epub 2009 Apr 3. J Cyst Fibros. 2009. PMID: 19345617
Azithromycin for improving pulmonary function in cystic fibrosis.
Carr RR, Nahata MC. Carr RR, et al. Ann Pharmacother. 2004 Sep;38(9):1520-4. doi: 10.1345/aph.1D589. Epub 2004 Jun 22. Ann Pharmacother. 2004. PMID: 15213312 Review.
Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.
Mall M, Grubb BR, Harkema JR, O'Neal WK, Boucher RC. Mall M, et al. Nat Med. 2004 May;10(5):487-93. doi: 10.1038/nm1028. Epub 2004 Apr 11. Nat Med. 2004. PMID: 15077107
The role of azithromycin in patients with cystic fibrosis.
Yousef AA, Jaffe A. Yousef AA, et al. Paediatr Respir Rev. 2010 Jun;11(2):108-14. doi: 10.1016/j.prrv.2009.12.003. Epub 2010 Jan 21. Paediatr Respir Rev. 2010. PMID: 20416547 Review.

See all similar articles

Cited by

Impact of Azithromycin on the Quorum Sensing-Controlled Proteome of Pseudomonas aeruginosa.
Swatton JE, Davenport PW, Maunders EA, Griffin JL, Lilley KS, Welch M. Swatton JE, et al. PLoS One. 2016 Jan 25;11(1):e0147698. doi: 10.1371/journal.pone.0147698. eCollection 2016. PLoS One. 2016. PMID: 26808156 Free PMC article.
Azithromycin inhibits expression of the GacA-dependent small RNAs RsmY and RsmZ in Pseudomonas aeruginosa.
Pérez-Martínez I, Haas D. Pérez-Martínez I, et al. Antimicrob Agents Chemother. 2011 Jul;55(7):3399-405. doi: 10.1128/AAC.01801-10. Epub 2011 May 2. Antimicrob Agents Chemother. 2011. PMID: 21537014 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.